Asbjørn Mohr Drewes Selected Research

Referred Pain

2/2015	Efficacy and safety of PPC-5650 on experimental rectal pain in patients with irritable bowel syndrome.
7/2008	Viscero-somatic reflexes in referred pain areas evoked by capsaicin stimulation of the human gut.
7/2006	Somatosensory changes in the referred pain area before and after cholecystectomy in patients with uncomplicated gallstone disease.
7/2004	Cold and heat pain assessment of the human oesophagus after experimental sensitisation with acid.
3/2004	Dipolar source modelling of brain potentials evoked by painful electrical stimulation of the human sigmoid colon.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Asbjørn Mohr Drewes Research Topics

Disease

91	Pain (Aches) 04/2022 - 07/2003
15	Chronic Pancreatitis 01/2022 - 03/2007
11	Hyperalgesia 01/2016 - 07/2003
9	Gastroesophageal Reflux (GERD) 02/2015 - 05/2006
8	Opioid-Induced Constipation 01/2022 - 10/2012
8	Visceral Pain 10/2013 - 07/2006
7	Chronic Pain 01/2022 - 08/2010
6	Constipation 01/2021 - 04/2011
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2019
5	Inflammation (Inflammations) 11/2019 - 07/2008
5	Referred Pain 02/2015 - 03/2004
4	Fibrosis (Cirrhosis) 06/2021 - 07/2008
4	Cancer Pain 01/2021 - 01/2018
4	Postoperative Pain 01/2016 - 04/2013
4	Hypersensitivity (Allergy) 04/2015 - 08/2009
3	Pancreatitis 04/2022 - 03/2021
3	Polyneuropathies (Polyneuropathy) 01/2022 - 11/2019
3	Weight Loss (Weight Reduction) 06/2021 - 11/2013
3	Disease Progression 04/2020 - 01/2019
3	Exocrine Pancreatic Insufficiency 01/2019 - 05/2013
3	Abdominal Pain (Pain, Abdominal) 10/2015 - 08/2005
3	Myalgia 05/2015 - 09/2007
3	Neoplasms (Cancer) 09/2014 - 09/2011
3	Acute Pain 07/2014 - 09/2007
3	Nociceptive Pain 10/2013 - 09/2007
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Knee Osteoarthritis 01/2022 - 12/2021
2	Malnutrition (Nutritional Deficiencies) 01/2021 - 04/2015
2	Stroke (Strokes) 01/2021 - 04/2020
2	Atrophy 09/2020 - 10/2013
2	Diabetic Neuropathies (Diabetic Neuropathy) 11/2019 - 06/2011
2	Chest Pain (Chest Pains) 10/2013 - 05/2006
2	Nausea 10/2013 - 10/2012
2	Kidney Calculi (Kidney Stone) 10/2013 - 04/2013
1	Osteoarthritis 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022
1	Insulin Resistance 12/2021
1	Short Bowel Syndrome 01/2021

Drug/Important Bio-Agent (IBA)

32	Opioid Analgesics (Opioids)IBA 12/2021 - 07/2006
27	Analgesics (Analgesic Drugs)IBA 04/2022 - 09/2004
15	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2007
14	Morphine (MS Contin)FDA LinkGeneric 11/2015 - 07/2006
14	AcidsIBA 04/2015 - 07/2004
10	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022 - 07/2006
9	Capsaicin (Zostrix)FDA Link 10/2011 - 07/2003
6	Pharmaceutical PreparationsIBA 05/2015 - 03/2007
5	Tapentadol FDA Link 01/2022 - 06/2011
4	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2014
4	salicylhydroxamic acid (SHAM)IBA 01/2021 - 04/2015
4	Opioid Receptors (Opioid Receptor)IBA 10/2016 - 08/2009
3	PlacebosIBA 01/2022 - 01/2019
3	Liraglutide FDA Link 01/2022 - 11/2019
3	Pancreatic Elastase (Elastase)IBA 03/2021 - 02/2018
3	CytokinesIBA 11/2019 - 07/2008
3	Gabapentin (Neurontin)FDA LinkGeneric 07/2014 - 09/2007
3	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2014 - 09/2007
2	Capsules (Microcapsules)IBA 01/2022 - 01/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2009
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2022 - 12/2021
2	Amylases FDA Link 12/2021 - 01/2019
2	CreatineIBA 01/2020 - 01/2014
2	Protons (Proton)IBA 01/2019 - 01/2014
2	N-acetylaspartate (N-acetyl aspartate)IBA 01/2019 - 01/2014
2	Secretin FDA Link 03/2017 - 01/2017
2	Pain-FreeIBA 01/2016 - 08/2005
2	Acid Sensing Ion ChannelsIBA 02/2015 - 02/2015
2	Ketamine FDA LinkGeneric 09/2014 - 09/2009
2	EnzymesIBA 11/2013 - 05/2013
2	Matrix Metalloproteinases (MMPs)IBA 06/2012 - 03/2012
2	Proton Pump InhibitorsIBA 10/2011 - 01/2011
2	PlasticsIBA 01/2011 - 05/2006
1	Opiate AlkaloidsIBA 04/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 12/2021
1	Narcotic Antagonists (Opioid Antagonists)IBA 12/2021
1	methylnaltrexone FDA Link 12/2021
1	AdiponectinIBA 06/2021
1	Nonesterified Fatty Acids (NEFA)IBA 06/2021
1	Glucagon-Like Peptides (Enteroglucagon)IBA 06/2021
1	LeptinIBA 06/2021
1	Triglycerides (Triacylglycerol)IBA 03/2021
1	naldemedineIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	SolutionsIBA 01/2021
1	IncretinsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021

Therapy/Procedure

16	Analgesia 04/2022 - 05/2008
6	Therapeutics 01/2021 - 08/2011
4	Vagus Nerve Stimulation 01/2022 - 01/2017
3	Pain Management 10/2021 - 10/2010
3	Spinal Manipulation 04/2020 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2011
2	Chiropractic Manipulation 01/2021 - 01/2019
2	Intradermal Injections 01/2016 - 01/2009
2	Diffuse Noxious Inhibitory Control 10/2013 - 08/2010
2	Percutaneous Nephrolithotomy 10/2013 - 04/2013
2	Electrodes (Electrode) 07/2013 - 03/2004
2	Aftercare (After-Treatment) 01/2009 - 08/2005
1	Glycemic Control 12/2021